← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

CEO Michael Kauffman sold $146K of Karyopharm Therapeutics Inc.

Sold$145,723
$19.43Price
7,500Shares
−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Wed, Jul 15. Filed Fri, Jul 17, 12:26 PM ET, during the session. Not investment advice.